Characterization of G6PD Genotypes and Phenotypes on the Northwestern Thailand-Myanmar Border

Mutations in the glucose-6-phosphate dehydrogenase (G6PD) gene result in red blood cells with increased susceptibility to oxidative damage. Significant haemolysis can be caused by primaquine and other 8-aminoquinoline antimalarials used for the radical treatment of Plasmodium vivax malaria. The distribution and phenotypes of mutations causing G6PD deficiency in the male population of migrants and refugees in a malaria endemic region on the Thailand-Myanmar border were characterized. Blood samples for G6PD fluorescent spot test (FST), G6PD genotyping, and malaria testing were taken from 504 unrelated males of Karen and Burman ethnicities presenting to the outpatient clinics. The overall frequency of G6PD deficiency by the FST was 13.7%. Among the deficient subjects, almost 90% had the Mahidol variant (487G>A) genotype. The remaining subjects had Chinese-4 (392G>T), Viangchan (871G>A), Açores (595A>G), Seattle (844G>C) and Mediterranean (563C>T) variants. Quantification of G6PD activity was performed using a modification of the standard spectrophotometric assay on a subset of 24 samples with Mahidol, Viangchan, Seattle and Chinese-4 mutations; all samples showed a residual enzymatic activity below 10% of normal and were diagnosed correctly by the FST. Further studies are needed to characterise the haemolytic risk of using 8-aminoquinolines in patients with these genotypes.

[1]  N. Day,et al.  A Population Survey of the Glucose-6-Phosphate Dehydrogenase (G6PD) 563C>T (Mediterranean) Mutation in Afghanistan , 2014, PloS one.

[2]  S. Hay,et al.  Spatial distribution of G6PD deficiency variants across malaria-endemic regions , 2013, Malaria Journal.

[3]  F. Nosten,et al.  Malaria Burden and Artemisinin Resistance in the Mobile and Migrant Population on the Thai–Myanmar Border, 1999–2011: An Observational Study , 2013, PLoS medicine.

[4]  Anand P. Patil,et al.  G6PD Deficiency Prevalence and Estimates of Affected Populations in Malaria Endemic Countries: A Geostatistical Model-Based Map , 2012, PLoS medicine.

[5]  C. Hammerman,et al.  Quantitative neonatal glucose-6-phosphate dehydrogenase screening: distribution, reference values, and classification by phenotype. , 2012, The Journal of pediatrics.

[6]  K. Na-Bangchang,et al.  Prevalence and distribution of glucose-6-phosphate dehydrogenase (G6PD) variants in Thai and Burmese populations in malaria endemic areas of Thailand , 2011, Malaria Journal.

[7]  J. Baird,et al.  Performance of the CareStart™ G6PD Deficiency Screening Test, a Point-of-Care Diagnostic for Primaquine Therapy Screening , 2011, PloS one.

[8]  Nick Day,et al.  Glucose-6-phosphate dehydrogenase (G6PD) mutations and haemoglobinuria syndrome in the Vietnamese population , 2009, Malaria Journal.

[9]  G. Killeen,et al.  Effective and cheap removal of leukocytes and platelets from Plasmodium vivax infected blood , 2009, Malaria Journal.

[10]  Pardis C Sabeti,et al.  Allelic heterogeneity of G6PD deficiency in West Africa and severe malaria susceptibility , 2009, European Journal of Human Genetics.

[11]  Douglas Chesher,et al.  Evaluating assay precision. , 2008, The Clinical biochemist. Reviews.

[12]  A. Gbakima,et al.  G6PD deficiency assessment in Freetown, Sierra Leone, reveals further insight into the molecular heterogeneity of G6PD A- , 2008, Journal of Human Genetics.

[13]  I. Nuchprayoon,et al.  Glucose-6-phosphate dehydrogenase mutations in Mon and Burmese of southern Myanmar , 2008, Journal of Human Genetics.

[14]  L. Manco,et al.  Mutations and haplotype diversity in 70 Portuguese G6PD-deficient individuals: an overview on the origin and evolution of mutated alleles , 2007, Haematologica.

[15]  Nguyễn Thế Dũng,et al.  Seven different glucose-6-phosphate dehydrogenase variants including a new variant distributed in Lam Dong Province in southern Vietnam. , 2007, Acta medica Okayama.

[16]  D. Socheat,et al.  Glucose-6-phosphate dehydrogenase (G6PD) mutations in Cambodia: G6PD Viangchan (871G>A) is the most common variant in the Cambodian population , 2005, Journal of Human Genetics.

[17]  M. Matsuo,et al.  Molecular heterogeneity of glucose-6-phosphate dehydrogenase (G6PD) variants in the south of Thailand and identification of a novel variant (G6PD Songklanagarind). , 2005, Blood cells, molecules & diseases.

[18]  Jichun Wang,et al.  Glucose-6-phosphate dehydrogenase (G6PD) mutations in Myanmar: G6PD Mahidol (487G>A) is the most common variant in the Myanmar population , 2004, Journal of Human Genetics.

[19]  I. Nuchprayoon,et al.  Glucose‐6‐phosphate dehydrogenase (G6PD) mutations in Thailand: G6PD Viangchan (871G>A) is the most common deficiency variant in the Thai population , 2002, Human mutation.

[20]  H. Fujii,et al.  Distribution of glucose-6-phosphate dehydrogenase mutations in Southeast Asia , 2001, Human Genetics.

[21]  G. Patrinos,et al.  Molecular Heterogeneity of the Glucose-6-Phosphate Dehydrogenase Deficiency in the Hellenic Population , 2000, Human Heredity.

[22]  D. P. Smith,et al.  A glucose-6-phosphate dehydrogenase (G6PD) splice site consensus sequence mutation associated with G6PD enzyme deficiency. , 1997, Mutation research.

[23]  V. Cabrera,et al.  Human enzyme polymorphism in the Canary Islands. VII. G6PD Seattle in Canarians and North African Berbers. , 1996, Human heredity.

[24]  T. Tang,et al.  Neonatal jaundice and molecular mutations in glucose‐6‐phosphate dehydrogenase deficient newborn infants , 1996, American journal of hematology.

[25]  M. Cappellini,et al.  Molecular characterisation of the glucose-6-phosphate dehydrogenase (G6PD) Ferrara II variant , 1995, Human Genetics.

[26]  E. Beutler,et al.  The NT 1311 polymorphism of G6PD: G6PD Mediterranean mutation may have originated independently in Europe and Asia. , 1990, American journal of human genetics.

[27]  T. Vulliamy,et al.  G6PD mahidol, a common deficient variant in South East Asia is caused by a (163)glycine----serine mutation. , 1989, Nucleic acids research.

[28]  V. Cabrera,et al.  Human enzyme polymorphism in the Canary Islands. VI. Northwest African influence. , 1986, Human heredity.

[29]  J. Kaplan,et al.  International Committee for Standardization in Haematology: Recommended Methods for Red‐Cell Enzyme Analysis * , 1977, British journal of haematology.

[30]  S. Na-nakorn,et al.  G-6-PD Mahidol. The most common glucose-6-phosphate dehydrogenase variant in Thailand. , 1972, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[31]  H. Notopuro,et al.  Glucose-6-phosphate dehydrogenase deficiency. , 1972, Paediatrica Indonesiana.

[32]  Margaret Mitchell,et al.  Brief Report: Special Modifications of the Fluorescent Screening Method for Glucose-6-Phosphate Dehydrogenase Deficiency , 1968 .

[33]  P. Engel,et al.  Purification and detailed study of two clinically different human glucose 6-phosphate dehydrogenase variants, G6PD(Plymouth) and G6PD(Mahidol): Evidence for defective protein folding as the basis of disease. , 2008, Molecular genetics and metabolism.

[34]  Tizhen Yan,et al.  Incidence and complete molecular characterization of glucose-6-phosphate dehydrogenase deficiency in the Guangxi Zhuang autonomous region of southern China: description of four novel mutations. , 2006, Haematologica.

[35]  T. Vulliamy,et al.  The role of the G6PD AEth376G/968C allele in glucose-6-phosphate dehydrogenase deficiency in the seerer population of Senegal. , 2006, Haematologica.

[36]  V. Cabrera,et al.  Human enzyme polymorphism in the Canary Islands. IV. Eastern islands. , 1991, Human heredity.

[37]  G. Gaetani,et al.  Glucose-6-phosphate dehydrogenase deficiency in Italy. A study of the distribution and severity of the enzymatic defect. , 1969, Acta haematologica.

[38]  G. Gaetani,et al.  Glucose-6-Phosphate Dehydrogenase Deficiency in Italy , 1969 .

[39]  E. Beutler,et al.  Special modifications of the fluorescent screening method for glucose-6-phosphate dehydrogenase deficiency. , 1968, Blood.